Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02692755
Title Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer (PALINA)
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Georgetown University

Her2-receptor negative breast cancer


Fulvestrant + Palbociclib

Letrozole + Palbociclib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.